4//SEC Filing
Boudes Pol F 4
Accession 0000899243-20-008455
CIK 0001133416other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:32 PM ET
Size
5.7 KB
Accession
0000899243-20-008455
Insider Transaction Report
Form 4
Boudes Pol F
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2020-03-12+300,000→ 300,000 totalExercise: $1.75Exp: 2030-03-12→ Common Stock (300,000 underlying)
Footnotes (2)
- [F1]The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest as follows: (i) 20% on each of March 2, 2021, March 2, 2022, March 2, 2023 and (i) 40% on March 2, 2024.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001454771
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:32 PM ET
- Size
- 5.7 KB